vaccine Archive
-
July 15, 2020
Vanderbilt University Medical Center to recruit up to 1,000 volunteers for COVID-19 vaccine Trial
In late July, Vanderbilt University Medical Center will begin recruiting up to 1,000 volunteers in a late-stage study of an experimental COVID-19 vaccine developed by Moderna Inc. in collaboration with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health. -
July 14, 2020
VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial
An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial. -
November 14, 2019
RSV transmission in the Middle East
Understanding how RSV is transmitted, which strains dominate and how new strains emerge around the globe will guide better vaccine and anti-viral drug design. -
April 25, 2019
Low oxygen and antibody responses
Mark Boothby and colleagues are exploring the factors that contribute to antibody production and quality, which are key to our defense against pathogens and response to vaccines. -
June 8, 2018
A “public” target for HIV
Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus. -
May 21, 2018
New target to stop Ebola
A new Vanderbilt study suggests it may be possible to develop antibody therapies or a universal vaccine effective against multiple Ebola virus family members. -
February 23, 2018
Hope for an RSV vaccine
Newly discovered features in an RSV protein may be useful for rational structure-based vaccine design.